{"id":"https://openalex.org/W4362477201","doi":"https://doi.org/10.1158/1535-7163.22498738","title":"Supplementary Figure 4 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity","display_name":"Supplementary Figure 4 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362477201","doi":"https://doi.org/10.1158/1535-7163.22498738"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22498738","doi":"https://doi.org/10.1158/1535-7163.22498738","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498738","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.22498738","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100780036","display_name":"Yu Cao","orcid":"https://orcid.org/0000-0002-9682-0980","observed_orcids":["https://orcid.org/0000-0002-9682-0980"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Cao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038349275","display_name":"James D. Marks","orcid":"https://orcid.org/0000-0003-0562-3517","observed_orcids":["https://orcid.org/0000-0003-0562-3517"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101856574","display_name":"Qian Huang","orcid":"https://orcid.org/0000-0002-3778-2419","observed_orcids":["https://orcid.org/0000-0002-3778-2419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061278758","display_name":"Stephen I. Rudnick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen I. Rudnick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068012778","display_name":"Chiyi Xiong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiyi Xiong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073876235","display_name":"Walter N. Hittelman","orcid":"https://orcid.org/0000-0002-0048-6640","observed_orcids":["https://orcid.org/0000-0002-0048-6640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walter N. Hittelman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100580537","display_name":"Xiaoxia Wen","orcid":"https://orcid.org/0000-0002-7749-0744","observed_orcids":["https://orcid.org/0000-0002-7749-0744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoxia Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083046767","display_name":"John W. Marks","orcid":"https://orcid.org/0009-0000-0035-2872","observed_orcids":["https://orcid.org/0009-0000-0035-2872"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W. Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102752340","display_name":"Lawrence H. Cheung","orcid":"https://orcid.org/0000-0002-6715-6574","observed_orcids":["https://orcid.org/0000-0002-6715-6574"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence H. Cheung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003675387","display_name":"Kim Boland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim Boland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373897","display_name":"Chun Li","orcid":"https://orcid.org/0000-0002-2376-4703","observed_orcids":["https://orcid.org/0000-0002-2376-4703"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chun Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050269562","display_name":"Gregory Paul Adams","orcid":"https://orcid.org/0000-0003-4207-2881","observed_orcids":["https://orcid.org/0000-0003-4207-2881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory P. Adams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048281793","display_name":"Michael G. Rosenblum","orcid":"https://orcid.org/0000-0002-3044-6121","observed_orcids":["https://orcid.org/0000-0002-3044-6121"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael G. Rosenblum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9574999809265137,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-chain-antibody","display_name":"single-chain antibody","score":0.8939999938011169},{"id":"https://openalex.org/keywords/immunotoxins","display_name":"immunotoxins","score":0.7870000004768372},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9300000071525574},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.6679999828338623},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.781000018119812},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/irdye800","display_name":"IRDye800","score":0.7049999833106995},{"id":"https://openalex.org/keywords/tumor-imaging","display_name":"tumor imaging","score":0.421999990940094},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.8358696103096008},{"id":"https://openalex.org/C2776872082","wikidata":"https://www.wikidata.org/wiki/Q181874","display_name":"HER2/neu","level":4,"score":0.708844780921936},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5256128311157227},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.44510316848754883},{"id":"https://openalex.org/C3018816774","wikidata":"https://www.wikidata.org/wiki/Q290671","display_name":"Single chain","level":3,"score":0.4257926940917969},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41250425577163696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3784332871437073},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36116692423820496},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33467331528663635},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3247877359390259},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2650706171989441},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15111657977104187},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.08131730556488037},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22498738","doi":"https://doi.org/10.1158/1535-7163.22498738","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498738","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22498738.v1","doi":"https://doi.org/10.1158/1535-7163.22498738.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22498738.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_Single-Chain_Antibody-Based_Immunotoxins_Targeting_Her2_neu_Design_Optimization_and_Impact_of_Affinity_on_Antitumor_Efficacy_and_Off-Target_Toxicity/22498738/1/files/39957121.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22498738","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_Single-Chain_Antibody-Based_Immunotoxins_Targeting_Her2_neu_Design_Optimization_and_Impact_of_Affinity_on_Antitumor_Efficacy_and_Off-Target_Toxicity/22498738","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22498738","doi":"https://doi.org/10.1158/1535-7163.22498738","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498738","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4362477201.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362478068","https://openalex.org/W2117884978","https://openalex.org/W2324623325","https://openalex.org/W1980023938","https://openalex.org/W2117203118","https://openalex.org/W2070942888","https://openalex.org/W4361825112","https://openalex.org/W2154405539","https://openalex.org/W2007336991","https://openalex.org/W4393073646"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"2744KB,":[3],"Ex":[4],"vivo":[5],"optical":[6],"imaging":[7,26],"of":[8,18],"tumor":[9],"and":[10,15],"other":[11],"organs":[12],"after":[13],"24":[14],"72h":[16],"postinjection":[17],"IRDye800-MH3-B1/rGel":[19],"or":[20],"IRDye800-B1D3/rGel":[21],"using":[22],"the":[23],"Xenogen":[24],"IVIS":[25],"system.":[27]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}